158 related articles for article (PubMed ID: 29235267)
1. Nitrate Esters of Heteroaromatic Compounds as Candida albicans CYP51 Enzyme Inhibitors.
Smiljkovic M; Matsoukas MT; Kritsi E; Zelenko U; Grdadolnik SG; Calhelha RC; Ferreira ICFR; Sankovic-Babic S; Glamoclija J; Fotopoulou T; Koufaki M; Zoumpoulakis P; Sokovic M
ChemMedChem; 2018 Feb; 13(3):251-258. PubMed ID: 29235267
[TBL] [Abstract][Full Text] [Related]
2. Small-Molecule Inhibitors Targeting Sterol 14α-Demethylase (CYP51): Synthesis, Molecular Modelling and Evaluation Against Candida albicans.
Binjubair FA; Parker JE; Warrilow AG; Puri K; Braidley PJ; Tatar E; Kelly SL; Kelly DE; Simons C
ChemMedChem; 2020 Jul; 15(14):1294-1309. PubMed ID: 32459374
[TBL] [Abstract][Full Text] [Related]
3. Design and optimization of highly-selective fungal CYP51 inhibitors.
Hoekstra WJ; Garvey EP; Moore WR; Rafferty SW; Yates CM; Schotzinger RJ
Bioorg Med Chem Lett; 2014 Aug; 24(15):3455-8. PubMed ID: 24948565
[TBL] [Abstract][Full Text] [Related]
4. Lead optimization generates selenium-containing miconazole CYP51 inhibitors with improved pharmacological profile for the treatment of fungal infections.
Xu H; Yan ZZ; Guo MB; An R; Wang X; Zhang R; Mou YH; Hou Z; Guo C
Eur J Med Chem; 2021 Apr; 216():113337. PubMed ID: 33713977
[TBL] [Abstract][Full Text] [Related]
5. Pyridylethanol(phenylethyl)amines are non-azole, highly selective Candida albicans sterol 14α-demethylase inhibitors.
Ogris I; Zelenko U; Sosič I; Gobec M; Skubic C; Ivanov M; Soković M; Kocjan D; Rozman D; Golič Grdadolnik S
Bioorg Chem; 2021 Jan; 106():104472. PubMed ID: 33261849
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis and Antifungal Activity Evaluation of New Thiazolin-4-ones as Potential Lanosterol 14α-Demethylase Inhibitors.
Stana A; Vodnar DC; Tamaian R; Pîrnău A; Vlase L; Ionuț I; Oniga O; Tiperciuc B
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106743
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and antifungal activity of some new imidazole and triazole derivatives.
Rezaei Z; Khabnadideh S; Zomorodian K; Pakshir K; Kashi G; Sanagoei N; Gholami S
Arch Pharm (Weinheim); 2011 Oct; 344(10):658-65. PubMed ID: 21984016
[TBL] [Abstract][Full Text] [Related]
8. Antifungal screening and in silico mechanistic studies of an in-house azole library.
Sari S; Kart D; Sabuncuoğlu S; Doğan İS; Özdemir Z; Bozbey İ; Gencel M; Eşsiz Ş; Reynisson J; Karakurt A; Saraç S; Dalkara S
Chem Biol Drug Des; 2019 Sep; 94(5):1944-1955. PubMed ID: 31260179
[TBL] [Abstract][Full Text] [Related]
9. Molecular Docking Evaluation of Imidazole Analogues as Potent Candida albicans 14α-Demethylase Inhibitors.
Rani N; Kumar P; Singh R; Sharma A
Curr Comput Aided Drug Des; 2015; 11(1):8-20. PubMed ID: 26081558
[TBL] [Abstract][Full Text] [Related]
10. Stepwise design, synthesis, and in vitro antifungal screening of (Z)-substituted-propenoic acid derivatives with potent broad-spectrum antifungal activity.
Khedr MA
Drug Des Devel Ther; 2015; 9():4501-13. PubMed ID: 26309398
[TBL] [Abstract][Full Text] [Related]
11. Discovery of new azoles with potent activity against Candida spp. and Candida albicans biofilms through virtual screening.
Sari S; Kart D; Öztürk N; Kaynak FB; Gencel M; Taşkor G; Karakurt A; Saraç S; Eşsiz Ş; Dalkara S
Eur J Med Chem; 2019 Oct; 179():634-648. PubMed ID: 31279296
[TBL] [Abstract][Full Text] [Related]
12. Homology model, molecular dynamics simulation and novel pyrazole analogs design of Candida albicans CYP450 lanosterol 14 α-demethylase, a target enzyme for antifungal therapy.
Jacob K S; Ganguly S; Kumar P; Poddar R; Kumar A
J Biomol Struct Dyn; 2017 May; 35(7):1446-1463. PubMed ID: 27142238
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of ergosterol synthesis in Candida albicans by novel eugenol tosylate congeners targeting sterol 14α-demethylase (CYP51) enzyme.
Lone SA; Khan S; Ahmad A
Arch Microbiol; 2020 May; 202(4):711-726. PubMed ID: 31786635
[TBL] [Abstract][Full Text] [Related]
14. Oxidation of Isodrimeninol with PCC Yields Drimane Derivatives with Activity against
Marin V; Iturra A; Opazo A; Schmidt B; Heydenreich M; Ortiz L; Jiménez VA; Paz C
Biomolecules; 2020 Jul; 10(8):. PubMed ID: 32722158
[No Abstract] [Full Text] [Related]
15. In silico and in vitro screening to identify structurally diverse non-azole CYP51 inhibitors as potent antifungal agent.
Singh A; Paliwal SK; Sharma M; Mittal A; Sharma S; Sharma JP
J Mol Graph Model; 2016 Jan; 63():1-7. PubMed ID: 26579619
[TBL] [Abstract][Full Text] [Related]
16. Design and Synthesis of New Antifungals Based on N-Un-substituted Azoles as 14α Demethylase Inhibitor.
Davood A; Rahimi A; Iman M; Azerang P; Sardari S; Mahboubi A
Curr Comput Aided Drug Des; 2021; 17(2):235-243. PubMed ID: 32065093
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and bioactivity evaluation of novel arylalkene-amide derivatives as dual-target antifungal inhibitors.
Sun B; Dong Y; An Y; Liu M; Han J; Zhao L; Liu X
Eur J Med Chem; 2020 Nov; 205():112645. PubMed ID: 32791399
[TBL] [Abstract][Full Text] [Related]
18. The clinical candidate VT-1161 is a highly potent inhibitor of Candida albicans CYP51 but fails to bind the human enzyme.
Warrilow AG; Hull CM; Parker JE; Garvey EP; Hoekstra WJ; Moore WR; Schotzinger RJ; Kelly DE; Kelly SL
Antimicrob Agents Chemother; 2014 Dec; 58(12):7121-7. PubMed ID: 25224009
[TBL] [Abstract][Full Text] [Related]
19. Targeted potent antimicrobial benzochromene-based analogues: Synthesis, computational studies, and inhibitory effect against 14α-Demethylase and DNA Gyrase.
Fouda AM; Hassan AH; Eliwa EM; Ahmed HEA; Al-Dies AM; Omar AM; Nassar HS; Halawa AH; Aljuhani N; El-Agrody AM
Bioorg Chem; 2020 Dec; 105():104387. PubMed ID: 33130344
[TBL] [Abstract][Full Text] [Related]
20. Novel mannopyranoside esters as sterol 14α-demethylase inhibitors: Synthesis, PASS predication, molecular docking, and pharmacokinetic studies.
Matin MM; Chakraborty P; Alam MS; Islam MM; Hanee U
Carbohydr Res; 2020 Oct; 496():108130. PubMed ID: 32863019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
